Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Noa Dagan"'
Autor:
Samah Hayek, Joseph Levy, Galit Shaham, Noa Dagan, Danielle Serby, Hadar Duskin-Bitan, Adva Yarden, Cátia Ferreira, Idit Livnat, Sabada Dube, Sylvia Taylor, Sudhir Venkatesan, Ran D. Balicer, Doron Netzer, Alon Peretz
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 6, Pp 1379-1389 (2024)
Abstract Introduction AZD7442 is a combination of two neutralizing antibodies (tixagevimab/cilgavimab) with demonstrated efficacy in reducing the risk of symptomatic coronavirus disease 2019 (COVID-19) among individuals at high risk of severe COVID-1
Externí odkaz:
https://doaj.org/article/52cfb12d1cc84267bb6d71cf712d6288
Autor:
Samah Hayek, Yatir Ben-shlomo, Noa Dagan, Ben Y. Reis, Noam Barda, Eldad Kepten, Alina Roitman, Shachar Shapira, Shlomit Yaron, Ran D. Balicer, Doron Netzer, Alon Peretz
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-5 (2022)
REGEN-COV is a SARS-CoV-2 combined monoclonal antibody treatment which has been shown to be effective in randomised controlled trials. Here, the authors assess its real-world effectiveness using data from Israel during the Delta wave and find that it
Externí odkaz:
https://doaj.org/article/fe8ce1b0e0424ad1a50cfef1a4a471b5
Autor:
Jacob G. Waxman, Maya Makov-Assif, Ben Y. Reis, Doron Netzer, Ran D. Balicer, Noa Dagan, Noam Barda
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-6 (2022)
The relative degree of immunity to SARS-CoV-2 provided by combinations of natural infection, vaccination, and booster doses is unknown. Here, the authors show that infection-induced immunity provides more protection against COVID-19-related hospitali
Externí odkaz:
https://doaj.org/article/1567ec2120bb4bb08a48c7dd4f06fe2c
Publikováno v:
IEEE Access, Vol 9, Pp 91584-91592 (2021)
This work presents a novel method for applying test-time augmentation (TTA) to tabular data. We used TTA along with an ensemble of 42 models to achieve higher performance on the MIT Global Open Source Severity of Illness Score dataset consisting of 1
Externí odkaz:
https://doaj.org/article/ebc84f1edfb04aaab40429ff8463a941
Autor:
Noam Barda, Dan Riesel, Amichay Akriv, Joseph Levy, Uriah Finkel, Gal Yona, Daniel Greenfeld, Shimon Sheiba, Jonathan Somer, Eitan Bachmat, Guy N. Rothblum, Uri Shalit, Doron Netzer, Ran Balicer, Noa Dagan
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-9 (2020)
Identification of individuals at risk of severe COVID-19 disease could inform treatment and public health planning. Here, the authors develop and validate a risk prediction model for COVID-19 mortality in Israel by building a model for severe respira
Externí odkaz:
https://doaj.org/article/b6f41c67d1bb44c58e4540ffa24f6729
Autor:
Dana Bielopolski, Gilad Libresco, Noam Barda, Noa Dagan, Tali Steinmetz, Dafna Yahav, David M Charytan, Ran D Balicer, Benaya Rozen-Zvi
Publikováno v:
Clinical Kidney Journal. 15:1838-1846
Background Chronic kidney disease (CKD) is a risk factor for severe coronavirus disease 2019 (COVID-19). We aimed to evaluate the real-life effectiveness of the BNT162b2 messenger RNA vaccine for a range of outcomes in patients with CKD compared with
Autor:
Sadiya S. Khan, Noam Barda, Philip Greenland, Noa Dagan, Donald M. Lloyd-Jones, Ran Balicer, Laura J. Rasmussen-Torvik
Publikováno v:
Am J Cardiol
Heart failure prevalence is increasing worldwide and is associated with significant morbidity and mortality. Guidelines emphasize prevention in those at risk, but HF-specific risk prediction equations developed in US population-based cohorts lack ext
Autor:
Galia Spectre, Idan Goldberg, Ran D. Balicer, Anat Gafter-Gvili, Noam Barda, Noa Dagan, Avi Leader, Pia Raanani
Publikováno v:
Journal of Thrombosis and Haemostasis. 20:635-647
BACKGROUND Emerging data suggest increased arterial thrombosis risk in the months preceding a cancer diagnosis. OBJECTIVES Assess whether patients without documented vascular risk factors or pre-existent cardiovascular disease have a higher relative
Autor:
Mark A. Katz, Efrat Bron Harlev, Bibiana Chazan, Michal Chowers, David Greenberg, Alon Peretz, Sagi Tshori, Joseph Levy, Mili Yacobi, Avital Hirsch, Doron Amichay, Ronit Weinberger, Anat Ben Dor, Elena Keren Taraday, Dana Reznik, Chen Barazani Chayat, Dana Sagas, Haim Ben Zvi, Rita Berdinstein, Gloria Rashid, Yonat Shemer Avni, Michal Mandelboim, Neta Zuckerman, Nir Rainy, Amichay Akriv, Noa Dagan, Eldad Kepten, Noam Barda, Ran D. Balicer
Publikováno v:
Vaccine
Background Methodologically rigorous studies on Covid-19 vaccine effectiveness (VE) in preventing SARS-CoV-2 infection are critically needed to inform national and global policy on Covid-19 vaccine use. In Israel, healthcare personnel (HCP) were init
Autor:
Noa Dagan, Ran D. Balicer, Ran Kornowski, Oren Auster, Tzlil Grinberg, Ilan Richter, Noam Barda, Guy Witberg, Sara Hoss, Maya Wiessman, Yaron Aviv
Publikováno v:
The New England Journal of Medicine
Background Reports have suggested an association between the development of myocarditis and the receipt of messenger RNA (mRNA) vaccines against coronavirus disease 2019 (Covid-19), but the frequency and severity of myocarditis after vaccination have